
Will Anduril's valuation hit (LOW) $65B by December 31?
Will Anduril's valuation hit __ by December 31?
AI analysis
This market resolves Yes if Anduril's valuation reaches or exceeds the low $65B threshold by December 31. This concerns a private defense company whose valuation is set in funding rounds and confirmed by public reporting on capital raises. The 3% market price effectively implies the market barely believes even the lowest rung will be hit.
The key fact: Anduril was already valued near $30.5B in its 2025 round, with revenue and contract backlog growing at double-digit rates amid demand for autonomous defense systems and drones. On that trajectory a new round at a $65B valuation is a realistic base case, not an extreme one: doubling valuation in a year is routine for a fast-growing defense contractor in this environment. The model gives 90% because the threshold is low relative to the company's trajectory.
For the outcome to win, one announced round or secondary transaction at $65B or above before year-end suffices. The market may be mispriced due to thin liquidity and because participants conflate the low threshold with the aggressive upper rungs of the ladder.
Main risks: no new round before the deadline, deal delays, and ambiguity in resolution wording (which source counts as official). If no publicly confirmed valuation appears by late December, the idea goes to zero.
Not investment advice. Trade at your own risk.